Overview

Transdermal drug delivery system market is expected to reach a CAGR of 4% over the forecast period 2022-2028.

The growth of this market has been determined by assessing the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems.

The growing levels of persistent diseases have meant that there has been a boost in the biotechnology and pharmaceuticals sectors. This, in turn, has allowed for exponential growth in the market worldwide. There are several applications within these systems which are useful in various ailments ranging from hormonal disorders to pain management and cardiovascular diseases. These are all factors which will see a boost in growth opportunities for the transdermal drug in upcoming years. These significantly reduced pain in patients, non-invasiveness is what is helping to keep the market afloat. Thus, drug delivery systems contain many disadvantages such as irritation of the edema, which may restrain the global transdermal drug delivery system market growth.

The market is divided based on type, end-user and application. The transdermal patches are further fragmented into drug-in-adhesive patches, microneedle patches matrix patches, reservoir membrane patches and. The transdermal semisolids will have sprays, gels and ointments.

This study will include an outline of the drug chain industry as well as the industry environment, and then will assess the market size and finally, it's forecast.

According to the applications, the market is shown to be fragmented by different segments such as hormonal disorders, along with other such ailments, smoking cessation and overactive bladder treatment. In the year 2020, the pain management segment is predicted to reach the largest of the transdermal drug delivery system and the transdermal patches segment is also expected to increase at a higher rate.

Key players included in the Transdermal Drug Delivery System Market are:

Hisamitsu Pharmaceutical, Mylan, UCB, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Johnson & Johnson, Endo International, and Purdue Pharma.

Competitive Landscape:

There are rising levels of diseases such as that of chronic pain, cardiovascular diseases, central nervous systems disorders. Seeing how common these diseases are, has resulted in the increased use of contraceptives and has allowed for further research into the market of transdermal drug delivery systems.
Transdermal drug delivery systems market has been identified as a profitable target market. This has resulted in there being many international players, such as Mylan, who manufacture high quality innovative transdermal drug delivery systems, such as adhesive patches.

Transdermal Drug Delivery System Segmentation:

By Type

Transdermal Patches
Transdermal Semisolids

By Application

Pain Management
Hormonal Applications
Central Nervous System Disorders
Cardiovascular Diseases
Other Applications

By End User

Hospitals & Cardiac Centers
Ambulatory Surgery Centers

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide an exhaustive analysis on global transdermal drug delivery system market by type, by application, by end user and by region.
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies
To evaluate and forecast micro-markets and the overall market

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com